Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Minority Interest (2016 - 2025)

Historic Minority Interest for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $388.8 million.

  • Sanofi's Minority Interest rose 396.18% to $388.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $388.8 million, marking a year-over-year increase of 396.18%. This contributed to the annual value of $377.5 million for FY2025, which is 36.01% down from last year.
  • As of Q4 2025, Sanofi's Minority Interest stood at $388.8 million, which was up 396.18% from $28.3 million recorded in Q2 2025.
  • In the past 5 years, Sanofi's Minority Interest ranged from a high of $400.4 million in Q4 2021 and a low of $18.3 million during Q2 2024
  • Its 5-year average for Minority Interest is $203.1 million, with a median of $196.7 million in 2022.
  • As far as peak fluctuations go, Sanofi's Minority Interest skyrocketed by 13480.59% in 2022, and later plummeted by 4993.81% in 2023.
  • Over the past 5 years, Sanofi's Minority Interest (Quarter) stood at $400.4 million in 2021, then dropped by 6.23% to $375.5 million in 2022, then decreased by 10.3% to $336.8 million in 2023, then rose by 11.06% to $374.0 million in 2024, then rose by 3.96% to $388.8 million in 2025.
  • Its Minority Interest was $388.8 million in Q4 2025, compared to $28.3 million in Q2 2025 and $374.0 million in Q4 2024.